Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: A nationwide population-based study with age-specific analyses

European Journal of Contraception and Reproductive Health Care

Volumn 17, Issue 2, 2012, Pages 106-118

  Lindberg, Malou ^a   Foldemo, Anniqa ^a   Josefsson, Ann ^a   Wiréhn, Ann Britt ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Antidepressants; Combined hormonal contraceptives; Depression; Hormonal contraceptives; Mood; Progestin only contraceptives; Registries

Indexed keywords

ANTIDEPRESSANT AGENT; CONTRACEPTIVE AGENT; DESOGESTREL; DROSPIRENONE; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; LYNESTRENOL; MEDROXYPROGESTERONE; NORETHISTERONE;

ADOLESCENT; ADULT; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; REVIEW; RISK; SWEDEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIDEPRESSIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DESOGESTREL; DRUG UTILIZATION; FEMALE; HUMANS; LEVONORGESTREL; LOGISTIC MODELS; LYNESTRENOL; MEDROXYPROGESTERONE; NORGESTREL; ODDS RATIO; OXIMES; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; REGISTRIES; SWEDEN;

EID: 84858389666     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2012.658925     Document Type: Review

References (33)

1. Frye CA. An overview of oral contraceptives: mechanism of action and clinical use. Neurology 2006;66(6 Suppl. 3):S29-36. (Pubitemid 43739806)
2. Brunnhuber S, Kirchengast S. Use of the oral contraceptive pill by Austrian adolescents with emphasis on the age of onset, side effects, compliance and lifestyle. Coll Antropol 2002;26:467-75.
3. Robinson SA, Dowell M, Pedulla D, McCauley L. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms? Med Hypotheses 2004;63:268-73. (Pubitemid 38968728)
4. Duke JM, Sibbritt DW, Young A F. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception 2007;75:27-31. (Pubitemid 44856722)
5. Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opin Drug Saf 2007;6:371-4. (Pubitemid 351308165)
6. Segebladh B, Borgström A, Odlind V, et al. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception 2009;79:50-5.
7. Berenson AB, Odom SD, Breitkopf CR, Rahman M. Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. Am J Obstet Gynecol 2008;199:351. e1-12.
8. Douma SL, Husband C, O'Donnell ME, et al. Estrogen-related mood disorders: reproductive life cycle factors. ANS Adv Nurs Sci 2005;28:364-75. (Pubitemid 41693494)
9. Lakdawalla Z, Hankin BL, Mermelstein R. Cognitive theories of depression in children and adolescents: a conceptual and quantitative review. Clin Child Fam Psy-chol Rev 2007;10:1-24.
10. Kendler K, Gardner CO, Prescott CA. Toward a comprehensive development model for major depression in women. Am J Psychiatry 2002;159:1133-45. (Pubitemid 34743253)
11. Spence SH, Shortt AL. Research review: can we justify the widespread dissemination of universal, school-based interventions for the prevention of depression among children and adolescents? J Child Psychol Psychiatry 2007;48:526-42. (Pubitemid 46902323)
12. Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuro-science can inform hormone therapy in women. J Neurosci 2006;26:10332-48. (Pubitemid 44564581)
13. Wiréhn AB, Foldemo A, Josefsson A, Lindberg M. Use of hormonal contraceptives in relation to antidepressant therapy: a nationwide population-based study. Eur J Contracept Reprod Health Care 2010;15:41-7.
14. The National Board of Health and Welfare. Health care report 2009 (In Swedish). Stockholm, Sweden: The National Board of Health and Welfare 2009.
15. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16:726-35. (Pubitemid 47180362)
16. Statistics Sweden Befolkningsstatistik The Total Population Register. Accessed 15 September 2009 from: http://www.ssd.scb.se/databaser/makro/start.asp
17. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research, 4th edn. Oxford: Blackwell Science Ltd. 2002: 117.
18. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models, 4th edn. Chicago, IL: Irwin 1996: 1215.
19. Oinonen KA, Mazmanian D. To what effect do oral contraceptives influence mood and affect? J Affect Disord 2002;70:229-40. (Pubitemid 34786641)
20. Birkhäuser M. Depression, menopause and estrogens: is there a correlation? Maturitas 2002;41(Suppl. 1):S3-8. (Pubitemid 34310509)
21. Deecher D, Andree TH, Sloan D, Schechter LE. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008;33:3-17.
22. Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res 2007;62:473-85. (Pubitemid 46441264)
23. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. J Psychiatr Res 2008;42:247-51. (Pubitemid 350266724)
24. Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 2006;28:3-8. (Pubitemid 41827562)
25. Klier CM, Muzik M, Dervic K, et al. The role of estrogen and progesterone in depression after birth. J Psychi-atr Res 2007;41:273-9. (Pubitemid 44855000)
26. Sangi-Haghpeykar H, Poindexter AN 3rd, Bateman L, Ditmore JR. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol 1996;88: 227-33. (Pubitemid 26250297)
27. Archer B, Irwin D, Jensen K, et al. Depot medroxypro-gesterone. Management of side-effects commonly associated with its contraceptive use. J Nurs Midwifery 1997;42:104-11. (Pubitemid 127749889)
28. Fraser IS, Dennerstein GJ. Depo-Provera use in an Australian metropolitan practice. Med J Aust 1994;160: 553-6. (Pubitemid 24127595)
29. Civic D, Scholes D, Ichikawa L, et al. Depressive symptoms in users and non-users of depot medroxyproges-terone acetate. Contraception 2000;61:385-90. (Pubitemid 30665814)
30. Westhoff C, Wieland D, Tiezzi L. Depression in users of depo-oxyprogesterone acetate. Contraception 1995;51: 351-4.
31. Westhoff C, Truman C, Kalmuss D, et al. Depressive symptoms and Depo-Provera. Contraception 1998;57:237-40.
32. Gupta N, O'Brien R, Jacobsen LJ, et al. Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study. J Pediatr Adolesc Gynecol 2001;14:71-6. (Pubitemid 32750303)
33. Chang YT, Hayter M, Wu SC. A systematic review and meta-ethnography of the qualitative literature: experiences of the menarche. J Clin Nurs 2010;19: 447-60.